NCT05938218View on ClinicalTrials.gov

Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions
Amyloidosis CardiacVirtual Reality
Interventions
DEVICE

Intervention

Virtual Reality assisted information Patients in the intervention group receive a VR instructional application lasting approximately 25 minutes. This intervention takes place in the waiting room prior to the actual physician-patient conversation and complements the usual care provided through brochures.

Trial Locations (1)

40225

University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine [Recruiting] Düsseldorf, Germany, 40225, Düsseldorf

All Listed Sponsors
lead

Heinrich-Heine University, Duesseldorf

OTHER

NCT05938218 - Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start Treatment | Biotech Hunter | Biotech Hunter